Annals of Oncology

News:

Once again: Natural is not benign
Ann Oncol 12: 1499.
[PDF] [Request Permissions]

The sorcerer's apprentice
Ann Oncol 12: 1499.
[PDF] [Request Permissions]

Sleep: A need that one should not neglect
Ann Oncol 12: 1499.
[PDF] [Request Permissions]

Swiss revolution?
Ann Oncol 12: 1499.
[PDF] [Request Permissions]

More on the benefits of smoking
Ann Oncol 12: 1500-1501.
[PDF] [Request Permissions]

A great Russian scientist has died
Ann Oncol 12: 1501.
[PDF] [Request Permissions]

There is no ‘clean war’
Ann Oncol 12: 1501.
[PDF] [Request Permissions]

Appointment
Ann Oncol 12: 1501-1502.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 12: 1502-1503.
[PDF] [Request Permissions]

Book reviews:

A. Engert

Book review
Ann Oncol 12: 1504.
[PDF] [Request Permissions]

S. Aebi

Book review
Ann Oncol 12: 1654.
[PDF] [Request Permissions]

Editorials:

C Tondini, P. Fenaroli, and R. Labianca

Pre-operative endocrine therapy for postmenopausal women: When and why?
Ann Oncol 12: 1505-1506.
[PDF] [Request Permissions]

T. J Key

Glycemic index, hyperinsulinemia, and breast cancer risk
Ann Oncol 12: 1507-1509.
[PDF] [Request Permissions]

Reviews:

J. Cuzick

Time to consider HPV testing in cervical screening
Ann Oncol 12: 1511-1514.
[PDF] [Request Permissions]

I. Sekine and N. Saijo

Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents
Ann Oncol 12: 1515-1525.
[Abstract] [PDF] [Request Permissions]

Original articles:

W. Eiermann, S. Paepke, J. Appfelstaedt, A. Llombart-Cussac, J. Eremin, J. Vinholes, L. Mauriac, M. Ellis, M. Lassus, H. A. Chaudri-Ross, M. Dugan, M. Borgs, and V. Semiglazov

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
Ann Oncol 12: 1527-1532.
[Abstract] [PDF] [Request Permissions]

L. S. A. Augustin, L. Dal Maso, C. La Vecchia, M. Parpinel, E. Negri, S. Vaccarella, C.W.C. Kendall, D. J. A. Jenkins, and S. Franceschi

Dietary glycemic index and glycemic load, and breast cancer risk: A case-control study
Ann Oncol 12: 1533-1538.
[Abstract] [PDF] [Request Permissions]

P. Carlini, A. Frassoldati, S. De Marco, A. Casali, E. M. Ruggeri, M. Nardi, P. Papaldo, A. Fabi, F. Paoloni, and F. Cognetti

Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?
Ann Oncol 12: 1539-1543.
[Abstract] [PDF] [Request Permissions]

G. Fountzilas, D. Tsavdaridis, A. Kalogera-Fountzila, Ch. Christodoulou, E. Timotheadou, Ch. Kalofonos, P. Kosmidis, A. Adamou, P. Papakostas, H. Gogas, G. Stathopoulos, E. Razis, D. Bafaloukos, D. Skarlos, and A Hellenic Cooperative Oncology Group phase II study

Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer
Ann Oncol 12: 1545-1551.
[Abstract] [PDF] [Request Permissions]

S. Fogli, R. Danesi, F. De Braud, T. De Pas, G. Curigliano, E. Giovannetti, and M. Del Tacca

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer
Ann Oncol 12: 1553-1559.
[Abstract] [PDF] [Request Permissions]

A. Kao, S. C. Shiun, N. Y. Hsu, S. S. Sun, C. C. Lee, and C. C. Lin

Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer: Relationship to chemotherapy response (six courses of combination ofcisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression
Ann Oncol 12: 1561-1566.
[Abstract] [PDF] [Request Permissions]

C. Huisman, P. E. Postmus, G. Giaccone, and E. F. Smit

A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients
Ann Oncol 12: 1567-1573.
[Abstract] [PDF] [Request Permissions]

C. D. Blanke, D. G. Haller, A. B. Benson, M. L. Rothenberg, J. Berlin, M. Mori, Y.-Ch. Hsieh, and L. L. Miller

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
Ann Oncol 12: 1575-1580.
[Abstract] [PDF] [Request Permissions]

J. L. Grem, L. K. Yee, B. Schuler, J. M. Hamilton, A. P. Chen, C. Chabuk, F. Grollman, M. Grabenc, C. J. Allegra, and C. H. Takimoto

N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma
Ann Oncol 12: 1581-1587.
[Abstract] [PDF] [Request Permissions]

E. Bidoli, C. La Vecchia, R. Talamini, E. Negri, M. Parpinel, E. Conti, M. Montella, A. Carbone, and S. Franceschi

Micronutrients and ovarian cancer: A case-control study in Italy
Ann Oncol 12: 1589-1593.
[Abstract] [PDF] [Request Permissions]

X. Pivot, S. Wadler, C. Kelly, R. Ruxer, J. Tortochaux, J. Stern, D. Belpomme, Y. Humblet, C. Domenge, N. Clendeninn, A. Johnston, C. Penning, and M. Schneider

Result of two randomized trials comparing nolatrexed (Thymitaq^TM) versus methotrexate in patients with recurrent head and neck cancer
Ann Oncol 12: 1595-1599.
[Abstract] [PDF] [Request Permissions]

P. Picci, D. Vanel, A. Briccoli, K. Talle, U. Haakenaasen, C. Malaguti, C. Monti, C. Ferrari, G. Bacci, G. Saeter, and T.A. Alvegard

Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation
Ann Oncol 12: 1601-1604.
[Abstract] [PDF] [Request Permissions]

D. Rades, G. Kühnel, I. Wildfang, A. R. Börner, H. J. Schmoll, and W. Knapp

Localised disease in cancer of unknown primary (CUP): The value of positron emission tomography (PET) for individual therapeutic management
Ann Oncol 12: 1605-1609.
[Abstract] [PDF] [Request Permissions]

B. Djulbegovic, J. R. Adams, G. H. Lyman, M. Lacevic, I. Hozo, M. Greenwich, and C. L. Bennett

Evaluation and appraisal of randomized controlled trials in myeloma
Ann Oncol 12: 1611-1617.
[Abstract] [PDF] [Request Permissions]

M. Paulussen, S. Ahrens, M. Lehnert, D. Taeger, H. W. Hense, A. Wagner, J. Dunst, D. Harms, A. Reiter, G. Henze, C. Niemeyer, U. Göbel, B. Kremens, U. R. Fölsch, W. E. Aulitzky, P. A.Voûte, A. Zoubek, and H. Jürgens

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
Ann Oncol 12: 1619-1630.
[Abstract] [PDF] [Request Permissions]

M. L. Rothenberg, J. G. Kuhn, L. J. Schaaf, G.I. Rodriguez, S. G. Eckhardt, M. A. Villalona-Calero, D. A. Rinaldi, L. A. Hammond, S. Hodges, A. Sharma, G. L. Elfring, R. G. Petit, P. K. Locker, L. L. Miller, and D. D. von Hoff

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
Ann Oncol 12: 1631-1641.
[Abstract] [PDF] [Request Permissions]

M. Marty, P. Fumoleau, A. Adenis, Y. Rousseau, Y. Merrouche, G. Robinet, J. Senac, and C. Puozzo

Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors
Ann Oncol 12: 1643-1649.
[Abstract] [PDF] [Request Permissions]

Clinical case:

T. De Pas, G. Curigliano, L. Franceschelli, C. Catania, L. Spaggiari, and F. de Braud

Gemcitabine-induced systemic capillary leak syndrome
Ann Oncol 12: 1651-1652.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

D Tassinari, S. Sartori, and A. Ravaioli

Staging of breast cancer. Is the evidence so evident?
Ann Oncol 12: 1653.
[PDF] [Request Permissions]

B. Schüll, G.V Kornek, and W Scheithauer

Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule
Ann Oncol 12: 1653-1654.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.